• Exchange: Soc.Bol SIBE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GRF:SM

33.2050 EUR 0.5850 1.79%

As of 11:35:03 ET on 12/19/2014.

Snapshot for Grifols SA (GRF)

Open: 32.8800 Day's Range: 32.5000 - 33.6400 Volume: 3,501,094
Previous Close: 32.6200 52wk Range: 27.9100 - 42.5300 1-Yr Rtn: -0.26%

Stock Chart for GRF

No chart data available.
  • GRF:SM 33.2050
  • 1D
  • 1M
  • 1Y
32.6200
Interactive GRF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GRF

Current P/E Ratio (ttm) 27.5318
Estimated P/E(12/2014) 19.4068
Relative P/E vs. IBEX 1.2671
Earnings Per Share (EUR) (ttm) 1.2061
Est. EPS (EUR) (12/2014) 1.7110
Est. PEG Ratio 1.2844
Market Cap (M EUR) 10,787.06
Shares Outstanding (M) 213.06
30 Day Average Volume 1,401,075
Price/Book (mrq) 4.5045
Price/Sale (ttm) 3.6322
Dividend Indicated Gross Yield 0.76%
Cash Dividend (EUR) 0.1986
Dividend Ex-Date 12/04/2014
5 Year Dividend Growth 9.54%
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GRF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GRF

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, Enteral nutrition, diagnostic systems, and medical materials.

Victor Grifols RouraChairman/CEORamon Riera RocaExec VP/Pres:Global Commercial
Alfredo Arroyo GuerraVP/CFOCarlos Roura FernandezVP/Pres:Global Industrial
More Company Profile & Key Executives for GRF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil